DO
DOCG.LSE L&G Healthcare Breakthrough UCITS ETF
- GBX
No recent price
- Total assets
- 56.9M
- Expense ratio
- 0.49%
- Dividend yield
- 0.44%
- 1-year return
- +36.98%
- Holdings
- 60
- Since
- 2019
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does DOCG.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (80.4%)
- Largest sector: Healthcare (98.4%)
- Largest region: North America (78.3%)
- Top 3 holdings: 7.7% of the fund
Asset allocation
- US stocks 80.4%
- Non-US stocks 20.1%
- Cash 0.1%
Top holdings
- GRAIL, LLC 2.88%
- CareDx Inc 2.43%
- Twist Bioscience Corp 2.38%
- Natera Inc 2.31%
- Intuitive Surgical Inc 2.26%
L&G Healthcare Breakthrough UCITS ETF performance
Sharpe ratio 1.17- This year
- +28.46%
- 1 year
- +36.98%
- 3 years
- +25.63%
- 5 years
- -0.30%
Volatility 17.0% over 1 year and 18.0% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
DOCG.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
L&G Healthcare Breakthrough UCITS ETF top holdings
22.7% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| GRAIL, LLC GRAL.US | Healthcare | United States | 2.88% |
| CareDx Inc CDNA.US | Healthcare | United States | 2.43% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 2.38% |
| Natera Inc NTRA.US | Healthcare | United States | 2.31% |
| Intuitive Surgical Inc ISRG.US | Healthcare | United States | 2.26% |
| Moderna Inc MRNA.US | Healthcare | United States | 2.17% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 2.17% |
| Glaukos Corp GKOS.US | Healthcare | United States | 2.08% |
| Guardant Health Inc GH.US | Healthcare | United States | 2.06% |
| Tempus AI, Inc. Class A Common Stock TEM.US | Healthcare | United States | 1.94% |
The 10 largest of 60 holdings.
DOCG.LSE sector exposure
- Healthcare98.4%
- Technology1.5%
Share of the stocks in the fund.
DOCG.LSE regional exposure
- North America78.3%
- Europe Developed14.3%
- Asia Emerging2.5%
- United Kingdom2.0%
- Japan1.2%
Share of the stocks in the fund.
Company size
Average market cap 17.7B- Mega cap1.7%
- Big cap20.0%
- Medium cap38.7%
- Small cap26.2%
- Micro cap13.3%
L&G Healthcare Breakthrough UCITS ETF fund profile
- Fund name
- L&G Healthcare Breakthrough UCITS ETF
- Ticker
- DOCG.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Jun 26, 2019
- Trading currency
- GBX
- Expense ratio
- 0.49%